Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06024512 · ClinicalTrials.gov registry record

DeepView Snapshot Handheld (DV-H) Comparison Study

A clinical trial, sponsored by SpectralMD.

Completed
Registry status
18
Enrollment target

NCT06024512: Completed study, sponsored by SpectralMD.

NCT06024512 is a clinical trial that has completed, run by SpectralMD. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06024512 has completed, sponsored by SpectralMD.

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

his study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate healing versus non-healing burn tissue. This device, if approved, is expected to give caregivers a better understanding of what parts of burn wounds will likely not heal on their own and as a tool used by the military in the field. This current study involves the collection of images over the course of your clinical treatment and follow-up according to your routine standard of care. The device will not be used to diagnose or prescribe treatment for your burn

Primary Outcome

The primary objective of this study is to demonstrate that the proposed SA-MSI sensor is equivalent or better than the current LC-MSI sensor. To conduct this test, we will compare the performance of the burn assessment AI algorithm using the image sensor as input data to the same Algorithm using the lens cluster data as an input.

Interventions

  • DEVICE Burn

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2023-06-13
Est. Completion 2024-01-25
SpectralMD

5 total trials

What the finished NCT06024512 record still lists

NCT06024512 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Burn is the first listed.

NCT06024512 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06024512 about?

NCT06024512 is a clinical study titled "DeepView Snapshot Handheld (DV-H) Comparison Study". his study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate he...

What is the current status of trial NCT06024512?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2023-06-13. Estimated completion is 2024-01-25.

What interventions are being tested in trial NCT06024512?

The interventions under investigation include: Burn (DEVICE).

Who is sponsoring clinical trial NCT06024512?

This trial is sponsored by SpectralMD, which has 5 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06024512, the US trial registry maintained by the National Library of Medicine. NCT06024512 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.